<DOC>
	<DOCNO>NCT00479466</DOCNO>
	<brief_summary>A study compare MK0893 metformin placebo patient Type 2 diabetes ( Diabetes Mellitus ) .</brief_summary>
	<brief_title>Dose-Range Finding Study MK0893 ( 0893-008 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Patients Type 2 Diabetes Mellitus , suboptimal glucose control , either AHA ( antihyperglycemic agent ) therapy monotherapy lowdose combination therapy Patients history Type 1 Diabetes Mellitus Patients take insulin thiazolidinedione ( TZD , peroxisome proliferatoractivated receptor [ PPAR ] gamma agonist ) Patients contraindication metformin</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>